Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Pfaar

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Allergy|September 30, 2015
A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II studyO Pfaar, E van Twuijver, J D Boot, et al.
Clinical and Translational Allergy|July 3, 2020
Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019V Mahler, D Mentzer, A Bonertz, et al.
Pneumologie (Stuttgart, Germany)|August 11, 2011
[Skin tests for diagnostics of allergic immediate-type reactions. Guideline of the German Society for Allergology and Clinical Immunology]F Ruëff, K-C Bergmann, K Brockow, et al.
HNO|December 6, 2011
[Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery]B A Stuck, C Bachert, P Federspil, et al.
Allergy|May 21, 2018
Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapyM Worm, T Higenbottam, O Pfaar, et al.
Allergy|January 26, 2017
Novel approaches and perspectives in allergen immunotherapyH J Hoffmann, E Valovirta, O Pfaar, et al.
Allergy|February 12, 2016
A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patientsO Pfaar, M J Nell, J D Boot, et al.
Clinical and Translational Allergy|September 19, 2019
Contraindications to immunotherapy: a global approachC Pitsios, M Tsoumani, M B Bilò, et al.
European Annals of Allergy and Clinical Immunology|September 6, 2023
Eosinophilic esophagitis as a side-effect of allergen immunotherapy: protocol for a systematic review and meta-analysisC Pitsios, C M Rossi, I Terreehorst, et al.
Allergy|March 8, 2018
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trialR Mösges, C Bachert, P Panzner, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Allergy|September 30, 2015
A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II studyO Pfaar, E van Twuijver, J D Boot, et al.
Clinical and Translational Allergy|July 3, 2020
Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019V Mahler, D Mentzer, A Bonertz, et al.
Pneumologie (Stuttgart, Germany)|August 11, 2011
[Skin tests for diagnostics of allergic immediate-type reactions. Guideline of the German Society for Allergology and Clinical Immunology]F Ruëff, K-C Bergmann, K Brockow, et al.
HNO|December 6, 2011
[Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery]B A Stuck, C Bachert, P Federspil, et al.
Allergy|May 21, 2018
Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapyM Worm, T Higenbottam, O Pfaar, et al.
Allergy|January 26, 2017
Novel approaches and perspectives in allergen immunotherapyH J Hoffmann, E Valovirta, O Pfaar, et al.
Allergy|February 12, 2016
A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patientsO Pfaar, M J Nell, J D Boot, et al.
Clinical and Translational Allergy|September 19, 2019
Contraindications to immunotherapy: a global approachC Pitsios, M Tsoumani, M B Bilò, et al.
European Annals of Allergy and Clinical Immunology|September 6, 2023
Eosinophilic esophagitis as a side-effect of allergen immunotherapy: protocol for a systematic review and meta-analysisC Pitsios, C M Rossi, I Terreehorst, et al.
Allergy|March 8, 2018
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trialR Mösges, C Bachert, P Panzner, et al.
Pageof 13